Kala Bio annual operating margin
2015
2019
2020
2021
2022
Kala Bio's operating margin was −2,099.33% for fiscal 2022.
View full Kala Bio company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2022 | 2022-12-31 | −2,099.33% | −940.57 pp |
| 2021 | 2021-12-31 | −1,158.76% | +353.83 pp |
| 2020 | 2020-12-31 | −1,512.59% | −60.10 pp |
| 2019 | 2019-12-31 | −1,452.49% | +33983.07 pp |
| 2015 | 2015-12-31 | −35,435.56% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q3 2022 | 2022-09-30 | −3,468.81% | −2618.76 pp |
| Q2 2022 | 2022-06-30 | −1,236.76% | −284.78 pp |
| Q1 2022 | 2022-03-31 | −2,253.21% | −1386.27 pp |
| Q4 2021 | 2021-12-31 | −2,522.36% | −1227.28 pp |
| Q3 2021 | 2021-09-30 | −850.05% | +314.01 pp |
| Q2 2021 | 2021-06-30 | −951.98% | +1602.64 pp |
| Q1 2021 | 2021-03-31 | −866.93% | +1012.15 pp |
| Q4 2020 | 2020-12-31 | −1,295.08% | +416.53 pp |
| Q3 2020 | 2020-09-30 | −1,164.05% | +322.30 pp |
| Q2 2020 | 2020-06-30 | −2,554.62% | −1465.17 pp |
| Q1 2020 | 2020-03-31 | −1,879.08% | −143.88 pp |
| Q4 2019 | 2019-12-31 | −1,711.61% | — |
| Q3 2019 | 2019-09-30 | −1,486.35% | — |
| Q2 2019 | 2019-06-30 | −1,089.45% | — |
| Q1 2019 | 2019-03-31 | −1,735.21% | — |
Across the available reported history, Kala Bio's operating margin decreased from −1,158.76% to −2,099.33%, a change of −940.57 percentage points. The latest reported quarter, Q3 2022, shows −3,468.81%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Kala Bio filings at SEC.gov ↗